在具有正常认知功能的个体中,基于机器学习的轻度认知障碍的预测
Xia Wei Zhu1, Si Bo Liu2, Chen Hua Ji3
1School of Computer and Communication Engineering, University of Science and Technology Beijing, Beijing, China.
Frontiers in neurology
|February 19, 2024
概括
使用机器学习模型,可以预测健康个体的轻度认知障碍 (MCI) 风险. 结合临床数据和脑部成像,特别是白质高强度和血压,显著提高了预测准确度.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 医疗成像医学成像
背景情况:
- 以前的研究主要确定了轻度认知障碍 (MCI) 和痴呆症的危险因素.
- 这项研究的重点是确定认知正常个体中MCI的早期风险因素,以实现预防策略.
研究的目的:
- 开发一种预测模型,用于在认知正常人群中预测MCI的未来风险.
- 确定与MCI发展相关的关键临床和成像变量.
主要方法:
- 一项纵向回顾性研究,利用大脑MRI扫描,临床数据和认知评估超过3年.
- 应用多种机器学习算法,包括随机森林,支持向量机,后勤回归,极端梯度增强 (XGB) 和 naive Bayes.
- 使用临床和成像变量组合的预测模型的开发.
主要成果:
- 极端梯度增强 (XGB) 模型表现出卓越的分类性能.
- 在结合临床和成像变量时,预测准确率达到94.32%.
- 发现的关键预测因素是白质强度 (WMH) 程度 (特别是在额叶) 和缩血压 (SBP) 控制.
结论:
- 结合临床和成像数据的XGB模型为MCI风险预测提供了一个有希望的方法.
- 额叶白质过强度和静脉血压控制是预测MCI发展的关键因素.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.3K
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.9K
相关概念视频
Cognitive Development During Adulthood
109
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
109
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
